StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Harvard Bioscience's pe ratio was 489.0× on Jul 31, 2015, against 66.9× a year earlier. Over the last 4 years it ranged from 6.2× to 570.0×, with a median of 29.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jul 31, 2015489.0×+375.6
2014Dec 31, 2014113.4×−16.6
2013Oct 31, 2013130.0×+96.3
2012Dec 31, 201233.7×+27.5
2011Dec 30, 20116.2×−10.8
2010Dec 31, 201017.0×–

More Harvard Bioscience figures

See a number that looks wrong?